Answer
No. It is a bispecific T-cell engager that redirects immune T cells towards DLL3-positive cancer cells.
Sources for this answer
- PubMedPubMed · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.